Outcome Evaluation After Fertility Preservation

Sponsor
Chinese University of Hong Kong (Other)
Overall Status
Recruiting
CT.gov ID
NCT06043609
Collaborator
(none)
100
1
144.3
0.7

Study Details

Study Description

Brief Summary

It is important to evaluate outcomes after different fertility preservation strategies. Therefore, this study aims to assess the outcomes after different fertility preservation strategies and identify any factors that may affect their reproductive outcome.

Condition or Disease Intervention/Treatment Phase
  • Other: This is an observational cohort study

Detailed Description

All patients who have undergone or will seek fertility preservation services in PWH will be invited to participate. For those patients who have undergone fertility preservation services in PWH, when they come back to use their frozen gametes or embryos, they will also be invited to participate.

Medical record assessment When patients come for fertility preservation consultation in PWH, they will be invited to participate. The medical notes of these patients undergoing fertility preservation services will be reviewed. The baseline characteristics including the socio-demographic background, past medical history, details of the surgical procedures, and the subsequent reproductive outcome, will be obtained by reviewing their hospital record. The participants will not be required to take any extra procedures.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Outcome Evaluation After Fertility Preservation
Actual Study Start Date :
Sep 21, 2023
Anticipated Primary Completion Date :
Oct 1, 2033
Anticipated Study Completion Date :
Oct 1, 2035

Outcome Measures

Primary Outcome Measures

  1. To determine any factors that may affect the success rate of different fertility preservation methods. [10 years]

    The medical notes of these patients undergoing fertility preservation services will be reviewed. The baseline characteristics including the socio-demographic background will be obtained by reviewing their hospital record.

Secondary Outcome Measures

  1. To assess the pregnancy rate after different fertility preservation methods. [10 years]

    The medical notes of these patients undergoing fertility preservation services will be reviewed. The subsequent reproductive outcome will be obtained by reviewing their hospital record.

  2. To report on the frequency of surgical complications [10 years]

    The medical notes of these patients undergoing fertility preservation services will be reviewed. The details of the surgical procedures will be obtained by reviewing their hospital record.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged from 0-50 years old

  • Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;

  • Patients seek for fertility preservation services

Exclusion Criteria:

-Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Prince of Wales Hospital Hong Kong Hong Kong

Sponsors and Collaborators

  • Chinese University of Hong Kong

Investigators

  • Principal Investigator: Jacqueline CHUNG, MBBS, Chinese University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chung Pui Wah Jacqueline, Associate Professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT06043609
Other Study ID Numbers:
  • 2023.346
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 22, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2023